Dow Up 0.08% Nasdaq Down 0.30%

United Therapeutics Corporation (UTHR)

-NasdaqGS
130.12 Down 0.81(0.62%) 4:00PM EDT
|After Hours : 130.12 0.00 (0.00%) 4:16PM EDT - Nasdaq Real Time Price
Prev Close:130.93
Open:130.62
Bid:124.50 x 800
Ask:146.00 x 100
1y Target Est:114.79
Beta:1.77
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:128.23 - 131.97
52wk Range:76.02 - 131.97
Volume:1,323,898
Avg Vol (3m):805,620
Market Cap:6.15B
P/E (ttm):28.27
EPS (ttm):4.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
UTHRDown 0.62%6.15B
GILDUp 0.17%160.40B
PFEDown 0.59%192.76B

Key Statistics

Forward P/E (1 yr):13.22
P/S (ttm):5.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.49
Quarterly EPS Est (Sep-14) :1.97
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):3.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback